The graft versus host disease market is experiencing significant growth, driven by the ongoing adoption of branded therapies such as JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK compared to off-label ...
Sep. 20, 2024 — A research group has developed a new COVID-19 testing system using Janus particles -- microparticles with two sides possessing distinctive molecular properties. These particles ...